Fondazione IRCCS Istituto Nazionale dei Tumori di Milano

Milan, (mi) 20133

0 studies enrolling now · 2 studies all time

What they study most

Malignant Thymoma, Thymic Carcinoma

Studies at this site

• Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma — Stopped early
• Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy — Stopped early